IXICO plc is engaged in providing clinical trial services and technology to evaluate imaging endpoints as part of their drug development pipelines. While the clinical focus is dementia, the Company also supports clinical studies for other disease areas in the field of neuro-degeneration. The Company’s medical image management and analysis products are used by the global pharmaceutical industry to select patients for clinical trials and to assess the safety and efficacy of drugs in development. The Company’s technologies include TrialWire and TrialTracker. This technology has been used in the collection of patient data from more than 400 hospital sites around the world in several of the clinical trials of Alzheimer’s disease treatments. The Company is also translating its technology into decision-support tools for the diagnosis of dementia. These products, including the new medical device, Assessa, will assist healthcare professionals to provide diagnosis.